Both GI and GL may stimulate tumorigenesis by increasing the bioavailability of estradiol or endogenous concentrations of insulin-like growth factor I (IGF-I), which in vitro promotes the proliferation of myoma cells, increasing the display of IGF-I gene expression and protein synthesis. The gene discussed is IGF1; the disease is benign muscle neoplasm.